128 related articles for article (PubMed ID: 23113684)
21. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
22. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietins in tumours: the angiogenic switch.
Tait CR; Jones PF
J Pathol; 2004 Sep; 204(1):1-10. PubMed ID: 15307132
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.
Olsen MW; Ley CD; Junker N; Hansen AJ; Lund EL; Kristjansen PE
Neoplasia; 2006 May; 8(5):364-72. PubMed ID: 16790085
[TBL] [Abstract][Full Text] [Related]
25. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
Wang X; Zhang Z; Yao C
Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietins as serum biomarkers for lymphatic anomalies.
Le Cras TD; Mobberley-Schuman PS; Broering M; Fei L; Trenor CC; Adams DM
Angiogenesis; 2017 Feb; 20(1):163-173. PubMed ID: 27990590
[TBL] [Abstract][Full Text] [Related]
27. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
29. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
[TBL] [Abstract][Full Text] [Related]
31. Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects.
Cullberg KB; Christiansen T; Paulsen SK; Bruun JM; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Mar; 21(3):454-60. PubMed ID: 23401397
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
[TBL] [Abstract][Full Text] [Related]
33. Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone.
Wang L; Du F; Zhang HM; Zhang WJ; Wang HX
Braz J Med Biol Res; 2015 Aug; 48(8):736-42. PubMed ID: 26108099
[TBL] [Abstract][Full Text] [Related]
34. The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.
Bolkun L; Lemancewicz D; Sobolewski K; Mantur M; Semeniuk J; Kulczynska A; Kloczko J; Dzieciol J
Adv Med Sci; 2013; 58(1):118-25. PubMed ID: 23333895
[TBL] [Abstract][Full Text] [Related]
35. Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors.
Kathamuthu GR; Moideen K; Baskaran D; Sekar G; Rathinam S; Bharathi VJ; Ganeshan GR; Babu S
Int J Tuberc Lung Dis; 2018 May; 22(5):557-566. PubMed ID: 29663962
[TBL] [Abstract][Full Text] [Related]
36. Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma.
Bhaskar A; Gupta R; Kumar L; Sharma A; Sharma MC; Kalaivani M; Thakur SC
Leuk Lymphoma; 2012 Apr; 53(4):635-40. PubMed ID: 21973309
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections.
Bennuru S; Maldarelli G; Kumaraswami V; Klion AD; Nutman TB
Am J Trop Med Hyg; 2010 Oct; 83(4):884-90. PubMed ID: 20889885
[TBL] [Abstract][Full Text] [Related]
38. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
[TBL] [Abstract][Full Text] [Related]
39. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
40. Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells.
Chen H; Shi L; Yang X; Li S; Guo X; Pan L
Int J Hematol; 2010 Nov; 92(4):587-97. PubMed ID: 20945119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
